Atossa Therapeutics (ATOS) Competitors

Atossa Therapeutics (NASDAQ:ATOS) and SIGA Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings, profitability and community ranking.

Does the media favor ATOS or SIGA?

In the previous week, Atossa Therapeutics had 4 more articles in the media than SIGA Technologies. MarketBeat recorded 9 mentions for Atossa Therapeutics and 5 mentions for SIGA Technologies. SIGA Technologies' average media sentiment score of 0.72 beat Atossa Therapeutics' score of 0.46 indicating that SIGA Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Atossa Therapeutics	1 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SIGA Technologies	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is ATOS or SIGA more profitable?

SIGA Technologies has a net margin of 49.33% compared to Atossa Therapeutics' net margin of 0.00%. SIGA Technologies' return on equity of 49.06% beat Atossa Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Atossa Therapeutics	N/A	-35.74%	-33.51%
SIGA Technologies	49.33%	49.06%	38.72%

Which has preferable earnings & valuation, ATOS or SIGA?

SIGA Technologies has higher revenue and earnings than Atossa Therapeutics. Atossa Therapeutics is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atossa Therapeutics	N/A	N/A	-$30.09M	-$0.21	-4.42
SIGA Technologies	$120.33M	3.63	$68.07M	$0.67	9.12

Does the MarketBeat Community favor ATOS or SIGA?

Atossa Therapeutics received 238 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 65.50% of users gave Atossa Therapeutics an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote.

Company	Underperform	Outperform
Atossa Therapeutics	Outperform Votes 243 65.50%	Underperform Votes 128 34.50%
SIGA Technologies	Outperform Votes 5 23.81%	Underperform Votes 16 76.19%

Do analysts rate ATOS or SIGA?

Atossa Therapeutics currently has a consensus target price of $7.13, suggesting a potential upside of 667.78%. Given Atossa Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Atossa Therapeutics is more favorable than SIGA Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Atossa Therapeutics	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
SIGA Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more risk & volatility, ATOS or SIGA?

Atossa Therapeutics has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Comparatively, SIGA Technologies has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of ATOS or SIGA?

12.7% of Atossa Therapeutics shares are owned by institutional investors. Comparatively, 55.4% of SIGA Technologies shares are owned by institutional investors. 7.6% of Atossa Therapeutics shares are owned by company insiders. Comparatively, 1.5% of SIGA Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

SIGA Technologies beats Atossa Therapeutics on 9 of the 17 factors compared between the two stocks.